Application Period Open for Excellence in Pursuit of Health Equity Award

By MedTech Intelligence Staff
March 5, 2024


• Categories: 05-Quality/Regulatory, Care Delivery, Healthcare Policy, Patient Safety

The Joint Commission and Kaiser Permanente are now accepting applications for the 2024 Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity. The award program will recognize a healthcare organization that led an initiative that achieved a measurable, sustained reduction in one or more disparities.

Bernard J. Tyson, the late CEO and chairman of Kaiser Permanente, worked tirelessly to address the disparities that plague the U.S. healthcare system. Now in its fourth year, the award honors Tyson’s legacy by presenting organizations the opportunity to earn national recognition for their efforts to improve healthcare equity, as well as share best practices and lessons learned with thousands of organizations across the country.

All types of healthcare organizations that directly deliver care and have addressed disparities for any vulnerable population, including but not limited to race/ethnicity, gender, sexual orientation, age, disability, or socioeconomic status, may apply. In their application, organizations must provide data demonstrating how they have improved a disparity.

This year’s application period is open until Tuesday, April 30, at 11:59 p.m. CT. There is no cost to apply.

Please visit the Tyson Award webpage for more information and to submit an application. There are several resources available for applicants, including:

• Application criteria
• Application preview
• Application tip sheet
• Last year’s winning application

The 2023 recipient of the Tyson Award was the University of Chicago Medicine, which was recognized for its initiative, Systematic Treatment and Management of Postpartum Hypertension (STAMPP-HTN), which improved postpartum care for women with hypertensive disorders of pregnancy. UChicago Medicine eliminated the disparity in postpartum follow-up visit attendance between Black and white patients and significantly improved patients’ clinical outcomes.